Since KEGG pathway enrichment analysis revealed downregulation of JAK/STAT signaling pathway-associated genes in vitexin-treated U251 cells, it was therefore hypothesized that vitexin might inhibit glioblastoma growth and proliferation through suppressing the JAK/STAT signaling. This evidence concerns the gene SOAT1 and glioblastoma.